467 related articles for article (PubMed ID: 27540597)
1. Trends and challenges in immuno-oncology trials.
Kiernan B
Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
[TBL] [Abstract][Full Text] [Related]
2. Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms.
Song W; Das M; Chen X
Trends Cancer; 2020 Apr; 6(4):288-298. PubMed ID: 32209444
[TBL] [Abstract][Full Text] [Related]
3. [New immunological concepts in oncology].
Versicherungsmedizin; 2013 Sep; 65(3):156-7. PubMed ID: 24137899
[No Abstract] [Full Text] [Related]
4. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
Golan T; Milella M; Ackerstein A; Berger R
J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
[TBL] [Abstract][Full Text] [Related]
5. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
Cui X; Wang Q; Kang C
Front Immunol; 2021; 12():788733. PubMed ID: 34777399
[No Abstract] [Full Text] [Related]
6. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
7. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy.
Osipov A; Murphy A; Zheng L
Adv Cancer Res; 2019; 143():63-144. PubMed ID: 31202363
[TBL] [Abstract][Full Text] [Related]
8. [Immuno-oncology and precision medicine: The clinician point of view].
Borg C
Ann Pathol; 2017 Feb; 37(1):5-6. PubMed ID: 28159403
[No Abstract] [Full Text] [Related]
9. Cancer research: Promise of protection.
Chi KR
Nature; 2011 Mar; 471(7339):537-8. PubMed ID: 21438188
[No Abstract] [Full Text] [Related]
10. Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2-4, 2016.
Gallardo-Rincón D; Marquez JP; Celis E
Cancer Immunol Immunother; 2017 Sep; 66(9):1243-1247. PubMed ID: 28484800
[TBL] [Abstract][Full Text] [Related]
11. Immuno-oncology drug development forges on despite COVID-19.
Upadhaya S; Hubbard-Lucey VM; Yu JX
Nat Rev Drug Discov; 2020 Nov; 19(11):751-752. PubMed ID: 32948858
[No Abstract] [Full Text] [Related]
12. Immuno-oncology combinations: a review of clinical experience and future prospects.
Antonia SJ; Larkin J; Ascierto PA
Clin Cancer Res; 2014 Dec; 20(24):6258-68. PubMed ID: 25341541
[TBL] [Abstract][Full Text] [Related]
13. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany.
Quandt D; Seliger B
Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001
[No Abstract] [Full Text] [Related]
14. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
Blair AB; Murphy A
Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
[TBL] [Abstract][Full Text] [Related]
15. Impact of Precision Medicine in Oncology: Immuno-oncology.
Buchbinder EI; Hodi FS
Cancer J; 2023 Jan-Feb 01; 29(1):15-19. PubMed ID: 36693153
[TBL] [Abstract][Full Text] [Related]
16. Immuno-Oncology in China.
Lu S; Chabner BA
Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy in lung cancer: New concepts].
Goubet AG; Livartowski A; Romano E
Rev Mal Respir; 2018 Jun; 35(6):642-651. PubMed ID: 29941206
[TBL] [Abstract][Full Text] [Related]
18. Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.
Hickey RM; Kulik LM; Nimeiri H; Kalyan A; Kircher S; Desai K; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2017 Nov; 28(11):1487-1494. PubMed ID: 28912090
[TBL] [Abstract][Full Text] [Related]
19. Cancer vaccines.
Chekhun VF
Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
[No Abstract] [Full Text] [Related]
20. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
